KRAS and cholangiocarcinoma: Additionally, the transcriptomic profile of KRAS wild-type PDAC shared similarity with cholangiocarcinoma, so therapeutic approaches used in biliary tract cancers may also be taken into consideration in KRAS wild-type PDAC [53].